Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cancer of unknown primary derived from regressed breast cancer.
Pouyiourou M, Mokry T, Feszler M, Teifke A, Kreft A, Krämer A. Pouyiourou M, et al. J Cancer Res Clin Oncol. 2024 May 4;150(5):229. doi: 10.1007/s00432-024-05768-5. J Cancer Res Clin Oncol. 2024. PMID: 38703270 Free PMC article. No abstract available.
Nivolumab and ipilimumab in recurrent or refractory cancer of unknown primary: a phase II trial.
Pouyiourou M, Kraft BN, Wohlfromm T, Stahl M, Kubuschok B, Löffler H, Hacker UT, Hübner G, Weiss L, Bitzer M, Ernst T, Schütt P, Hielscher T, Delorme S, Kirchner M, Kazdal D, Ball M, Kluck K, Stenzinger A, Bochtler T, Krämer A. Pouyiourou M, et al. Nat Commun. 2023 Oct 24;14(1):6761. doi: 10.1038/s41467-023-42400-5. Nat Commun. 2023. PMID: 37875494 Free PMC article. Clinical Trial.
[Cancer of unknown primary-The new ESMO guidelines].
Bochtler T, Pouyiourou M, Krämer A. Bochtler T, et al. Among authors: pouyiourou m. Radiologie (Heidelb). 2023 May;63(5):329-335. doi: 10.1007/s00117-023-01126-7. Epub 2023 Mar 17. Radiologie (Heidelb). 2023. PMID: 36930265 Review. German.
First-line treatment with R-CHOP or rituximab-bendamustine in patients with follicular lymphoma grade 3A-results of a retrospective analysis.
Pouyiourou M, Meyer A, Stroux A, Viardot A, La Rosée P, Maschmeyer G, Kämpfe D, Kahl C, Vucinic V, Monecke A, Hirt C, Weber T, Meissner J, Witzens-Harig M, Böttcher S, Schmalenberg H, Marks R, Prange-Krex G, Kroschinsky F, Hauf E, Keller U, Koch K, Klapper W, Herold M, Scholz CW; East German Study Group for Hematology and Oncology (OSHO). Pouyiourou M, et al. Ann Hematol. 2020 Dec;99(12):2821-2829. doi: 10.1007/s00277-020-04171-7. Epub 2020 Jul 30. Ann Hematol. 2020. PMID: 32734548